Cleveland Clinic Innovations earns top spot
Joining a short list of global healthcare giants, the Cleveland Clinic's corporate arm has won a spot in one ranking of the world's most influential companies in healthcare commercialization.
Cleveland Clinic Innovations, which is responsible for creating companies using the health system's research in medical technology, was named by Global Corporate Venturing magazine as a top competitor in the entrepreneurial field.
The Clinic won a No. 4 spot with Novartis, Johnson & Johnson, Eli Lilly and Wellcome Trust also included in the top five. Company rankings were based on equity investment, venture capitalists reviews and other factors.
Cleveland Clinic Invents Artificial Smart Heart
It weighs less than a pound and Cleveland Clinic biomedical engineer Dr. Leonard Golding believes it is the future of the artificial heart that will not only keep people alive if they're waiting for a heart transplant or not, but also allow them to have a normal quality of life.
The unique device is one of the first high-tech advances since the artificial mechanical heart came on the market 30 years ago.
Foreign investors believe in it too. That's why Cleveland Heart, Inc., a Cleveland Clinic Innovations spin-off company, has received a $30 million investment that will fund further development and clinical trials for a total artificial heart.
MetroHealth, Explorys use huge patient database to revolutionize medical research
Large databases of electronic medical records hold great promise for medical research. In theory they can provide doctors access to huge amounts of anonymous patient data, allowing large-scale population studies without the cost and hassle of patient recruitment, review boards and staff training.
Now, a team of experts at MetroHealth Medical Center and the Cleveland Clinic Innovations spinoff company Explorys has shown just how powerful such medical records can be. In three months, they've replicated a major medical study that took a Norwegian team 14 years to research and report. And they've done it at a fraction of the cost, with a sample about 40 times as large.
Cleveland Clinic Spin-Off Company, Cleveland Heart Inc., Receives $30 Million Investment for Develop
Cleveland Heart, Inc., a Cleveland Clinic Innovations spin-off company, has received a $30 million investment that will fund further development and clinical trials for a total artificial heart.
Power Heart Consortium, a Korean private-equity group, made the investment to further the development of the SmartHeart Total Artificial Heart, which is a total artificial heart and left ventricular assist device (LVAD) designed for long-term, durable use in patients suffering from biventricular heart failure.